{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:23:12Z","timestamp":1772119392530,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T00:00:00Z","timestamp":1685836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T00:00:00Z","timestamp":1685836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"he key research and development (R&D) projects of Gansu Province","award":["17YF1FA126"],"award-info":[{"award-number":["17YF1FA126"]}]},{"name":"Lanzhou Science and Technology Bureau Medical and Health Project","award":["2021-90"],"award-info":[{"award-number":["2021-90"]}]},{"name":"CuiYing Science and Technology Innovation plan project of Lanzhou University Second Hospital","award":["CY2017-BJ05"],"award-info":[{"award-number":["CY2017-BJ05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00432-023-04907-8","type":"journal-article","created":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T04:01:18Z","timestamp":1685851278000},"page":"10269-10278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["What factors are associated with the prognosis of primary testicular diffuse large B-cell lymphoma? A study based on the SEER database"],"prefix":"10.1007","volume":"149","author":[{"given":"Shujun","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panfeng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,4]]},"reference":[{"issue":"3","key":"4907_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.urolonc.2022.10.032","volume":"41","author":"MB Berjaoui","year":"2023","unstructured":"Berjaoui MB, Herrera-Caceres JO, Li T et al (2023) Age related differences in primary testicular lymphoma: a population based cohort study. Urol Oncol 41(3):151. https:\/\/doi.org\/10.1016\/j.urolonc.2022.10.032","journal-title":"Urol Oncol"},{"issue":"5","key":"4907_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.eururo.2006.07.043","volume":"50","author":"FJ Bianco","year":"2006","unstructured":"Bianco FJ (2006) Nomograms and medicine. Eur Urol 50(5):884\u2013886. https:\/\/doi.org\/10.1016\/j.eururo.2006.07.043","journal-title":"Eur Urol"},{"issue":"21","key":"4907_CR3","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252\u20137259. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0713","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4907_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.urolonc.2020.02.027","volume":"38","author":"F Caumont","year":"2020","unstructured":"Caumont F, Porter C, DeBerg H et al (2020) Combined chemotherapy and radiotherapy improves survival in 1897 testicular lymphoma patients from a contemporary cohort. Urol Oncol 38(7):641. https:\/\/doi.org\/10.1016\/j.urolonc.2020.02.027","journal-title":"Urol Oncol"},{"issue":"4","key":"4907_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1182\/blood-2013-10-530659","volume":"123","author":"CY Cheah","year":"2014","unstructured":"Cheah CY, Wirth A, Seymour JF (2014) Primary testicular lymphoma. Blood 123(4):486\u2013493. https:\/\/doi.org\/10.1182\/blood-2013-10-530659","journal-title":"Blood"},{"issue":"1","key":"4907_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12885-020-6711-0","volume":"20","author":"B Chen","year":"2020","unstructured":"Chen B, Cao DH, Lai L et al (2020) Adult primary testicular lymphoma: clinical features and survival in a series of patients treated at a high-volume institution in China. BMC Cancer 20(1):220. https:\/\/doi.org\/10.1186\/s12885-020-6711-0","journal-title":"BMC Cancer"},{"issue":"4","key":"4907_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10552-008-9256-0","volume":"20","author":"LX Clegg","year":"2009","unstructured":"Clegg LX, Reichman ME, Miller BA et al (2009) Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: national longitudinal mortality study. Cancer Causes Control 20(4):417\u2013435. https:\/\/doi.org\/10.1007\/s10552-008-9256-0","journal-title":"Cancer Causes Control"},{"issue":"31","key":"4907_CR8","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1200\/JCO.2009.22.5896","volume":"27","author":"JD Gundrum","year":"2009","unstructured":"Gundrum JD, Mathiason MA, Moore DB et al (2009) Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab. J Clin Oncol 27(31):5227\u20135232. https:\/\/doi.org\/10.1200\/JCO.2009.22.5896","journal-title":"J Clin Oncol"},{"key":"4907_CR1001","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2147\/JIR","volume":"15","author":"D Guo","year":"2022","unstructured":"Guo D, Hong L, Ji H et al (2022) The mutation of BTG2 gene predicts a poor outcome in primary testicular diffuse large B-cell Lymphoma. J Inflamm Res 15:1757\u20131769. https:\/\/doi.org\/10.2147\/JIR","journal-title":"J Inflamm Res"},{"issue":"10","key":"4907_CR9","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.5858\/arpa.2010-0158-RS","volume":"135","author":"MJ Horne","year":"2011","unstructured":"Horne MJ, Adeniran AJ (2011) Primary diffuse large B-cell lymphoma of the testis. Arch Pathol Lab Med 135(10):1363\u20131367. https:\/\/doi.org\/10.5858\/arpa.2010-0158-RS","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"4907_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/bjh.14392","volume":"176","author":"R Kridel","year":"2017","unstructured":"Kridel R, Telio D, Villa D et al (2017) Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era. Br J Haematol 176(2):210\u2013221. https:\/\/doi.org\/10.1111\/bjh.14392","journal-title":"Br J Haematol"},{"issue":"2","key":"4907_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3324\/haematol.2018.200105","volume":"104","author":"SK Leivonen","year":"2019","unstructured":"Leivonen SK, Pollari M, Bruck O et al (2019) T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma. Haematologica 104(2):338\u2013346. https:\/\/doi.org\/10.3324\/haematol.2018.200105","journal-title":"Haematologica"},{"key":"4907_CR12","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3389\/fonc.2020.01356","volume":"10","author":"Y Liao","year":"2020","unstructured":"Liao Y, Yin G, Fan X (2020) The positive lymph node ratio predicts survival in T(1\u20134)N(1\u20133)M(0) non-small cell lung cancer: a nomogram using the SEER database. Front Oncol 10:1356. https:\/\/doi.org\/10.3389\/fonc.2020.01356","journal-title":"Front Oncol"},{"issue":"7","key":"4907_CR13","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3109\/10428191003793358","volume":"51","author":"A Mazloom","year":"2010","unstructured":"Mazloom A, Fowler N, Medeiros LJ et al (2010) Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience. Leuk Lymphoma 51(7):1217\u20131224. https:\/\/doi.org\/10.3109\/10428191003793358","journal-title":"Leuk Lymphoma"},{"issue":"23","key":"4907_CR14","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1182\/blood-2017-01-764209","volume":"129","author":"L Nayak","year":"2017","unstructured":"Nayak L, Iwamoto FM, LaCasce A et al (2017) PD-1 blockade with nivolumab in relapsed\/refractory primary central nervous system and testicular lymphoma. Blood 129(23):3071\u20133073. https:\/\/doi.org\/10.1182\/blood-2017-01-764209","journal-title":"Blood"},{"issue":"10216","key":"4907_CR15","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/S0140-6736(19)33008-9","volume":"394","author":"V Poeschel","year":"2019","unstructured":"Poeschel V, Held G, Ziepert M et al (2019) Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Lancet 394(10216):2271\u20132281. https:\/\/doi.org\/10.1016\/S0140-6736(19)33008-9","journal-title":"Lancet"},{"key":"4907_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164049","author":"M Pollari","year":"2021","unstructured":"Pollari M, Leivonen SK, Leppa S (2021) Testicular diffuse large B-cell lymphoma-clinical, molecular, and immunological features. Cancers (basel). https:\/\/doi.org\/10.3390\/cancers13164049","journal-title":"Cancers (basel)"},{"issue":"2","key":"4907_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.7150\/ijms.65517","volume":"19","author":"Y Shen","year":"2022","unstructured":"Shen Y, Wang L, Ou J et al (2022) Loss of 5-hydroxymethylcytosine as a poor prognostic factor for primary testicular diffuse large B-cell lymphoma. Int J Med Sci 19(2):225\u2013232. https:\/\/doi.org\/10.7150\/ijms.65517","journal-title":"Int J Med Sci"},{"issue":"1","key":"4907_CR18","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1080\/16078454.2022.2119345","volume":"27","author":"Y Sun","year":"2022","unstructured":"Sun Y, Yan X, Zhao H et al (2022) Characteristic features of primary testicular lymphoma and survival trends: a multicenter clinical study. Hematology 27(1):1019\u20131025. https:\/\/doi.org\/10.1080\/16078454.2022.2119345","journal-title":"Hematology"},{"issue":"9","key":"4907_CR1002","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1182\/blood.2020006338","volume":"137","author":"D Twa","year":"2021","unstructured":"Twa D, Lee DG, Tan KL et al (2021) Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma. Blood 137(9):1256\u20131259. https:\/\/doi.org\/10.1182\/blood.2020006338","journal-title":"Blood"},{"issue":"20","key":"4907_CR19","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1200\/JCO.2010.31.4187","volume":"29","author":"U Vitolo","year":"2011","unstructured":"Vitolo U, Chiappella A, Ferreri AJ et al (2011) First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial. J Clin Oncol 29(20):2766\u20132772. https:\/\/doi.org\/10.1200\/JCO.2010.31.4187","journal-title":"J Clin Oncol"},{"issue":"12","key":"4907_CR20","doi-asserted-by":"publisher","first-page":"e19463","DOI":"10.1097\/MD.0000000000019463","volume":"99","author":"Q Wang","year":"2020","unstructured":"Wang Q, Zheng D, Chai D et al (2020a) Primary testicular diffuse large B-cell lymphoma: case series. Medicine (baltimore) 99(12):e19463. https:\/\/doi.org\/10.1097\/MD.0000000000019463","journal-title":"Medicine (baltimore)"},{"key":"4907_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40364-020-00189-1","volume":"8","author":"X Wang","year":"2020","unstructured":"Wang X, Xu X, Cai W et al (2020b) TBL1XR1 mutation predicts poor outcome in primary testicular diffuse large B-cell lymphoma patients. Biomark Res 8:10. https:\/\/doi.org\/10.1186\/s40364-020-00189-1","journal-title":"Biomark Res"},{"issue":"3","key":"4907_CR22","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.3892\/ol.2019.9953","volume":"17","author":"H Xu","year":"2019","unstructured":"Xu H, Yao F (2019) Primary testicular lymphoma: a SEER analysis of 1,169 cases. Oncol Lett 17(3):3113\u20133124. https:\/\/doi.org\/10.3892\/ol.2019.9953","journal-title":"Oncol Lett"},{"issue":"6","key":"4907_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.6004\/jnccn.2019.0029","volume":"17","author":"AD Zelenetz","year":"2019","unstructured":"Zelenetz AD, Gordon LI, Abramson JS et al (2019) NCCN guidelines insights: B-cell lymphomas, version 3.2019. J Natl Compr Canc Netw 17(6):650\u2013661. https:\/\/doi.org\/10.6004\/jnccn.2019.0029","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04907-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-04907-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04907-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T09:16:41Z","timestamp":1691831801000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-04907-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,4]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4907"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-04907-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2839340\/v1","asserted-by":"object"}]},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,4]]},"assertion":[{"value":"20 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors involved in the writing of the article declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We selected the data from the SEER database, which is a public database and does not require ethical approval. We can find it from\n                      \n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}